InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,717.20
(
0.43%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.09
(
0.17%
)
Bitcoin
63,097.84
(
0.08%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 97

Thursday, 04/12/2018 7:48:44 AM

Thursday, April 12, 2018 7:48:44 AM

Post# of 438
AMRN topline Reduce-It results are expected Q3/18

Next earnings release will be around May 2.

will have plenty of cash when Reduce-It is read out.

Vascepa YOY growth is slowing. 2018 may get a boost if Vascepa continues to get approval in the countries of the middle east

Reduce-It resuls will have a huge impact on the stock.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up